Proposed Data Collections Submitted for Public Comment and Recommendations, 74017-74018 [2012-30021]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 239 / Wednesday, December 12, 2012 / Notices
register with Caroline Talev at
caroline.talev@hhs.gov; registration for
public comment will not be accepted by
telephone. Public comment will be
limited to two minutes per speaker. Any
members of the public who wish to have
printed material distributed to PACHA
members at the meeting should submit,
at a minimum, 1 copy of the materials
to Caroline Talev, no later than close of
business Thursday, January 31, 2013.
Contact information for the PACHA
contact person is listed above.
Dated: November 29, 2012.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2012–29910 Filed 12–11–12; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
mstockstill on DSK4VPTVN1PROD with
Dated: December 3, 2012.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
conference call. The call will be open to
the public.
DATES: The call will be held January 7,
2013 at 1:00 p.m. (EST) to
approximately 2:00 p.m. (EST).
ADDRESSES: The call-in number is 800–
857–1237 and the participant pass code
is 7293236.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Assistant,
Presidential Advisory Council on HIV/
AIDS, Department of Health and Human
Services, 200 Independence Avenue
SW., Room 443H, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
205–1178. More detailed information
about PACHA can be obtained by
accessing the Council’s Web site
www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995 as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
SUMMARY:
VerDate Mar<15>2010
15:48 Dec 11, 2012
Jkt 229001
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention of HIV disease and AIDS.
The functions of the Council are solely
advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the Council’s Web site at
www.aids.gov/pacha.
Pre-registration for the call is
advisable and can be accomplished by
contacting Caroline Talev at
caroline.talev@hhs.gov. Members of the
public will have the opportunity to
listen in on the phone call.
[FR Doc. 2012–30026 Filed 12–11–12; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0009]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
74017
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Disease Surveillance
Program (OMB No. 0920–0009
Expiration 4/30/2013)—Extension—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Formal surveillance of 16 separate
reportable diseases has been ongoing to
meet the public demand and scientific
interest in accurate, consistent,
epidemiologic data. These ongoing
disease reports include: CreutzfeldtJakob Disease (CJD), Cyclosporiasis,
Dengue, Hantavirus, Kawasaki
Syndrome, Legionellosis, Lyme disease,
Malaria, Plague, Q Fever, Reye
Syndrome, Tickborne Rickettsial
Disease, Trichinosis, Tularemia,
Typhoid Fever, and Viral Hepatitis.
Case report forms from state and
territorial health departments enable
CDC to collect demographic, clinical,
and laboratory characteristics of cases of
these diseases. There are no changes
since the last submission.
The purpose of the proposed study is
to direct epidemiologic investigations,
identify and monitor trends in
reemerging infectious diseases or
emerging modes of transmission, to
search for possible causes or sources of
the diseases, and develop guidelines for
prevention and treatment. The data
collected will also be used to
recommend target areas most in need of
vaccinations for selected diseases and to
determine development of drug
resistance. Because of the distinct
nature of each of the diseases, the
number of cases reported annually is
different for each. There is no cost to
respondents other than their time.
E:\FR\FM\12DEN1.SGM
12DEN1
74018
Federal Register / Vol. 77, No. 239 / Wednesday, December 12, 2012 / Notices
Form
CJD ...................................................
Cyclosporiasis ...................................
Dengue ..............................................
Hantavirus .........................................
Kawasaki Syndrome .........................
Legionellosis .....................................
Lyme Disease ...................................
Malaria ..............................................
Plague ...............................................
Q Fever .............................................
Reye Syndrome ................................
Tick-borne Rickettsia ........................
Trichinosis .........................................
Tularemia ..........................................
Typhoid Fever ...................................
Viral hepatitis ....................................
Total ...........................................
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
2
10
182
3
8
12
385
20
1
1
1
18
1
2
6
200
20/60
15/60
15/60
20/60
15/60
20/60
10/60
15/60
20/60
10/60
20/60
10/60
20/60
20/60
20/60
25/60
13
138
2,503
40
110
92
3,337
275
4
9
17
165
8
37
110
4,583
...........................................................
........................
........................
........................
11,441
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10280 and CMS–
R–131]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
AGENCY:
mstockstill on DSK4VPTVN1PROD with
Total burden
hours
20
55
55
40
55
23
52
55
11
55
50
55
25
55
55
55
[FR Doc. 2012–30021 Filed 12–11–12; 8:45 am]
15:48 Dec 11, 2012
Avg. burden
per response
(in hrs)
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
..................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science
Office of the Director Centers for Disease
Control and Prevention.
VerDate Mar<15>2010
Number of
responses per
respondent
Number of
respondents
Type of respondent
Jkt 229001
1. Type of Information Collection
Request: New collection; Title: Home
Health Change of Care Notice (HHCCN);
Use: Home health agencies (HHAs) are
required to provide written notice to
original Medicare beneficiaries under
various circumstances involving the
initiation, reduction, or termination of
services. The notice used in these
situations has been the Home Health
Advance Beneficiary Notice (HHABN),
CMS–R–296.
The HHABN, originally a liability
notice specifically for HHA issuance,
was first approved for use and
implementation in 2000 with the home
health prospective payment system
transition. In 2006, the notice
underwent significant modifications
subsequent to the decision of the U.S.
Court of Appeals (2nd Circuit) in Lutwin
v. Thompson. HHABN content and
formatting were revised so that it could
be used to provide beneficiaries with
change of care notification consistent
with HHA Conditions of Participation
(COPs) in addition to its liability notice
function. Three interchangeable option
boxes were introduced to the HHABN to
support the added notification
purposes. Option Box 1 addressed
liability, Option Box 2 addressed change
of care for agency reasons, and Option
Box 3 addressed change of care due to
provider orders. HHABN Collection
0938–0781 last received PRA approval
in 2009 following minor notice changes
such as accessibility reformatting for
compliance with Section 508 of the
Rehabilitation Act of 1973, as amended
in 1998, and removal of the
beneficiary’s health insurance claim
number (HICN).
In an effort to streamline, reduce, and
simplify notices issued to Medicare
beneficiaries, HHABN Option Box 1, the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
liability notice portion, will be replaced
by the existing Advanced Beneficiary
Notice of Noncoverage (ABN) which is
approved by OMB (0938–0566), for
conveying information on beneficiary
liability. Written notices to inform
beneficiaries of their liability under
specific conditions have been available
since the ‘‘limitation on liability’’
provisions in section 1879 of the Social
Security Act were enacted in 1972 (Pub.
L. 92–603). The ABN (CMS–R–131) is
presently used by providers and
suppliers other than HHAs to inform fee
for service (FFS) Medicare beneficiaries
of potential liability for certain items/
services that might be billed to
Medicare. The HHABN was developed
specifically as the liability notice for
HHA issuance. Since 2006, the HHABN
has evolved to serve both liability and
change of care notification purposes.
Pursuant to a separate PRA package
revising the use of the ABN, HHAs will
now use the ABN for liability
notification, and the HHCCN will be
introduced as a separate, distinct
document to give change of care notice
in compliance with HHA conditions of
participation. The HHCCN will replace
both Option Box 2 and Option Box 3
formats of the HHABN. The single page
format of the HHCCN is designed to
specify whether the change of care is
due to agency reasons or provider
orders. Form Number: CMS–10280
(OCN: 0938–New); Frequency:
Occasionally; Affected Public: Private
Sector—Business or other for-profits
and not-for-profit institutions; Number
of Respondents: 10,914; Total Annual
Responses: 14,126,428; Total Annual
Hours: 941,385. (For policy questions
regarding this collection contact Evelyn
Blaemire at 410–786–1803. For all other
issues call 410–786–1326.)
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 77, Number 239 (Wednesday, December 12, 2012)]
[Notices]
[Pages 74017-74018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0009]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National Disease Surveillance Program (OMB No. 0920-0009 Expiration
4/30/2013)--Extension--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Formal surveillance of 16 separate reportable diseases has been
ongoing to meet the public demand and scientific interest in accurate,
consistent, epidemiologic data. These ongoing disease reports include:
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis, Dengue, Hantavirus,
Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q
Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis,
Tularemia, Typhoid Fever, and Viral Hepatitis. Case report forms from
state and territorial health departments enable CDC to collect
demographic, clinical, and laboratory characteristics of cases of these
diseases. There are no changes since the last submission.
The purpose of the proposed study is to direct epidemiologic
investigations, identify and monitor trends in reemerging infectious
diseases or emerging modes of transmission, to search for possible
causes or sources of the diseases, and develop guidelines for
prevention and treatment. The data collected will also be used to
recommend target areas most in need of vaccinations for selected
diseases and to determine development of drug resistance. Because of
the distinct nature of each of the diseases, the number of cases
reported annually is different for each. There is no cost to
respondents other than their time.
[[Page 74018]]
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Form Type of Number of responses per per response Total burden
respondent respondents respondent (in hrs) hours
----------------------------------------------------------------------------------------------------------------
CJD........................... Epidemiologist.. 20 2 20/60 13
Cyclosporiasis................ Epidemiologist.. 55 10 15/60 138
Dengue........................ Epidemiologist.. 55 182 15/60 2,503
Hantavirus.................... Epidemiologist.. 40 3 20/60 40
Kawasaki Syndrome............. Epidemiologist.. 55 8 15/60 110
Legionellosis................. Epidemiologist.. 23 12 20/60 92
Lyme Disease.................. Epidemiologist.. 52 385 10/60 3,337
Malaria....................... Epidemiologist.. 55 20 15/60 275
Plague........................ Epidemiologist.. 11 1 20/60 4
Q Fever....................... Epidemiologist.. 55 1 10/60 9
Reye Syndrome................. Epidemiologist.. 50 1 20/60 17
Tick-borne Rickettsia......... Epidemiologist.. 55 18 10/60 165
Trichinosis................... Epidemiologist.. 25 1 20/60 8
Tularemia..................... Epidemiologist.. 55 2 20/60 37
Typhoid Fever................. Epidemiologist.. 55 6 20/60 110
Viral hepatitis............... Epidemiologist.. 55 200 25/60 4,583
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 11,441
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science Office of the Director Centers for
Disease Control and Prevention.
[FR Doc. 2012-30021 Filed 12-11-12; 8:45 am]
BILLING CODE 4163-18-P
